Reported about 4 hours ago
GSK announced plans to invest $30 billion over the next five years in research and development and manufacturing infrastructure in the United States. This investment includes the construction of a new factory in Pennsylvania and advancements in AI and digital technology across its existing sites. U.S. Secretary of Commerce Howard Lutnick emphasized that this investment will generate tens of thousands of American jobs and enhance the development of essential medicines domestically, as GSK aims to strengthen its presence amidst looming tariffs on the pharmaceutical sector.
Source: YAHOO